Katogen Insights
LinkedInnewsletter · by Doug Drysdale
Weekly straight talk from Doug Drysdale on biopharma execution and lessons learned the hard way
- Audience
- Not shown publicly
- We show a dash rather than guess
- Observed frequency
- Weekly
- From 5 posts indexed in the last 90 days
- Last post
- Oct 19, 2026
- 16 days ago
- Likely audience
- Pharmaceutical executives
- Inferred from post content
Katogen Insights is a LinkedIn newsletter by Doug Drysdale covering M&A, Pharmaceuticals and Regulatory exclusivity. NewsletterFIT indexed 5 posts from it in the last 90 days, most recently on Oct 19, 2026.
Topics
- M&A
- Pharmaceuticals
- Regulatory exclusivity
- Orphan drug designation
- Clinical trials
Recent posts
- Katogen Insights:…
- Katogen Insights:…
- Katogen Insights:…
- Katogen Insights:…
- Katogen Insights:…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on Katogen Insights
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
Similar newsletters
Ranked by how many topics they share with Katogen Insights.
- GLP-1 Digest 2K subscribers
SubstackMonthly or less · last post 27 days ago
Likely audience: Healthcare investors
2 shared topics
- Unreported Truths223K subscribers
SubstackSeveral times a week · last post 5 days ago
Likely audience: public health professionals
1 shared topic
- The Microdose89K subscribers
SubstackWeekly · last post 2 days ago
Likely audience: Healthcare policy makers
1 shared topic
- Dr. Noc, PhD67K subscribers
SubstackWeekly · last post 3 days ago
Likely audience: Health-conscious individuals
1 shared topic
- Dr Paddy Barrett37K subscribers
SubstackWeekly · last post 4 days ago
Likely audience: Cardiologists and lipid specialists
1 shared topic
- MD REPORTS27K subscribers
SubstackSeveral times a week · last post 2 days ago
Likely audience: Public health advocates
1 shared topic
- Repurposed Drugs: Powers & Possibilities24K subscribers
SubstackEvery two weeks · last post 3 days ago
Likely audience: Public health officials
1 shared topic
- Thought Leader19K subscribers
SubstackEvery two weeks · last post 28 days ago
Likely audience: Medical professionals and neurosurgeons
1 shared topic
Compiled from public pages · refreshed Nov 4, 2026 · How NewsletterFIT collects and labels data